Hepatocellular Cancer Terminated Phase Trials for Bevacizumab (DB00112)

Also known as: Cancer, Hepatocellular

IndicationStatusPhase
DBCOND0037277 (Hepatocellular Cancer)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01507740Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients